Comparative proteomic studies of plasma from children with pneumococcal pneumonia

References

• Tan TQ, Mason EO, Jr, Barson WJ, Wald ER, Schutze GE, Bradley JS, et al. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae. Pediatrics 1998; 102: 1369–75
   PubMed Web of Science ®Google Scholar
• McCarthy VP, Patamasucon P, Gaines T, Lucas MA. Necrotizing pneumococcal pneumonia in childhood. Pediatr Pulmonol 1999; 28: 217–21
   PubMedGoogle Scholar
• Kerem E, Bar Ziv Y, Rudenski B, Katz S, Kleid D, Branski D. Bacteremic necrotizing pneumococcal pneumonia in children. Am J Respir Crit Care Med 1994; 149: 242–4
   PubMed Web of Science ®Google Scholar
• McCarthy VP, Patamasucon P, Gaines T, Lucas MA. Necrotizing pneumococcal pneumonia in childhood. Pediatr Pulmonol 1999; 28: 217–21
   PubMedGoogle Scholar
• Chen KC, Su YT, Lin WL, Chiu KC, Niu CK. Clinical analysis of necrotizing pneumonia in children: 3-y experience in a single medical center. Acta Paediatr Tw 2003; 44: 343–8
   Google Scholar
• Hsieh YC, Hsueh PR, Lu CY, Lee PI, Lee CY, Huang LM. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis 2004; 38: 830–5
   PubMed Web of Science ®Google Scholar
• Wu TT, Hsueh PR, Lee LN, Yang PC, Luh KT. Pneumonia caused by penicillin-non-susceptible Streptococcus pneumoniae: clinical characteristics, prognostic factors, and outcomes. J Formos Med Assoc 2000; 99: 18–23
   PubMedGoogle Scholar
• Weiser JN, Kapoor M. Effect of intrastrain variation in the amount of capsular polysaccharide on genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains. Infect Immun 1999; 67: 3690–2
   PubMed Web of Science ®Google Scholar
• Wan J, Sun W, Li X, Ying W, Dai J, Kuai X, et al. Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase. Proteomics 2006; 6: 2886–94
   PubMed Web of Science ®Google Scholar
• Hsieh SY, Shih TC, Yeh CY, Lin CJ, Chou YY, Lee YS. Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics 2006; 6: 5322–31
   PubMed Web of Science ®Google Scholar
• Hanash S. Disease proteomics. Nature 2003; 422: 226–32
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1: 845–67
   PubMed Web of Science ®Google Scholar
• Gruys E, Toussaint MJM, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ SCI 2005; 11: 1045–56
   Google Scholar
• Kadioglu A, Gingles NA, Grattan K, Kerr A, Mitchell TJ, Andrew PW. Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 2000; 68: 492–501
   PubMed Web of Science ®Google Scholar
• Yang F, Ghio AJ, Herbert DC, Weaker FJ, Walter CA, Coalson JJ. Pulmonary expression of the human haptoblogin gene. Am J Respir Cell Mol Biol 2000; 23: 277–82
   PubMed Web of Science ®Google Scholar
• Balla J, Nath KA, Balla G, Juckett MB, Jacob HS, Vercellotti GM. Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol 1995; 268: 321–7
   PubMed Web of Science ®Google Scholar
• Yang F, Haile DJ, Berger FG, Herbert DC, Beveren EV, Ghio AJ. Haptoglobin reduces lung injury associated with exposure to blood. Am J Physiol Lung Cell Mol Physiol 2003; 284: 402–9
   Google Scholar
• Oh SK, Pavlotsky N, Tauber AI. Specific binding of haptoglobin to human neutrophils and its function consequences. J Leukoc Biol 1990; 47: 142–8
   PubMed Web of Science ®Google Scholar
• Mateos-Cáceres PJ, García-Méndez A, López Farré A, Macaya C, Núñez A, Gómez J, et al. Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004; 44: 1578–83
   PubMed Web of Science ®Google Scholar
• van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, van Kessel KP. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003; 31: 1359–66
   PubMed Web of Science ®Google Scholar
• Levels JH, Abraham PR, van den Ende A, van Deventer SJ. Distribution and kinetics of lipoprotein-bound endotoxin. Infect Immun 2001; 69: 2821–8
   PubMed Web of Science ®Google Scholar
• Levels JH, Abraham PR, van Barreveld EP, Meijers JC, van Deventer SJ. Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect Immun 2003; 71: 3280–4
   PubMed Web of Science ®Google Scholar
• Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock 2004; 21: 210–21
   PubMedGoogle Scholar
• Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005; 33: 1688–93
   PubMed Web of Science ®Google Scholar
• Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885–91
   PubMed Web of Science ®Google Scholar
• Fraunberger P, Pilz G, Cremer P, Werdan K, Walli AK. Association of serum tumor necrosis factor levels with decrease of cholesterol during septic shock. Shock 1998; 10: 359–63
   PubMed Web of Science ®Google Scholar